SCHEMBL305339

SCHEMBL305339

O=C1OC(=O)C(Cc2ccccc2)=C1Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 1/20 0.52
CTRC Q99895 4/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
MAPK1 P28482 1/20 0.47
HIF1A Q16665 1/20 0.47
SORT1 Q99523 1/20 0.42
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
ALOX15 P16050 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
IDH1 O75874 2/20 0.40
ELANE P08246 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
GPR55 Q9Y2T6 1/20 0.40
DAO P14920 1/20 0.39
PTPN1 P18031 1/20 0.39
F2 P00734 1/20 0.39
PLG P00747 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL304780 0.89 TP53 (0.44) CALM1CTRCCYP1A2CYP2C9MAPK1
SCHEMBL304970 0.89 CALM1 (0.42) CALM1CTRCCYP1A2CYP2C9MAPK1
SCHEMBL304373 0.80 CYP1A2 (0.41) CALM1CYP1A2CYP2C9MAPK1HIF1A
SCHEMBL16431430 0.79 KDM4E (0.51) CYP1A2CYP2C9TDP1ELANEMEN1
SCHEMBL16431432 0.79 KDM4E (0.51) CYP1A2CYP2C9TDP1ELANEMEN1
SCHEMBL8132266 0.77 CALM1 (0.55) CALM1CTRCSORT1MAOAMAOB
SCHEMBL304454 0.76 ALDH1A1 (0.38) CYP1A2CYP2C9MAPK1HIF1ASORT1
SCHEMBL27623517 0.75 MAOA (0.57) CALM1CTRCCYP1A2CYP2C9MAPK1
SCHEMBL6495081 0.72 SORT1 (0.44) CALM1CTRCCYP1A2CYP2C9MAPK1
SCHEMBL3044017 0.71 HIF1A (0.48) CALM1CTRCCYP1A2CYP2C9MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3694902-B1 CURABLE RESIN COMPOSITION AND FIBER REINFORCED RESIN MATRIX COMPOSITE MATERIAL CYTEC IND INC (US) 2026-03-18 EP disclosed
CN-117924667-A Curable resin composition and fiber reinforced resin matrix composite 塞特工业公司 2024-04-26 CN disclosed
CN-111278885-B Curable resin composition and fiber reinforced resin matrix composite 塞特工业公司 2024-03-22 CN disclosed
US-11725103-B2 Curable resin composition and fiber reinforced resin matrix composite material CYTEC INDUSTRIES INC. (US) 2023-08-15 US disclosed
US-20200317909-A1 CURABLE RESIN COMPOSITION AND FIBER REINFORCED RESIN MATRIX COMPOSITE MATERIAL CYTEC INDUSTRIES INC. 2020-10-08 US disclosed
EP-3694902-A1 CURABLE RESIN COMPOSITION AND FIBER REINFORCED RESIN MATRIX COMPOSITE MATERIAL Cytec Industries Inc. (US) 2020-08-19 EP disclosed
CN-111278885-A Curable resin composition and fiber reinforced resin matrix composite 塞特工业公司 2020-06-12 CN disclosed
WO-2019074795-A1 CURABLE RESIN COMPOSITION AND FIBER REINFORCED RESIN MATRIX COMPOSITE MATERIAL CYTEC INDUSTRIES INC. (US) 2019-04-18 WO disclosed
US-20160151322-A1 METALLO-B-LACTAMASE INHIBITORS MEIJI SEIKA KAISHA (JP) 2016-06-02 US disclosed
US-20160151322-A1 METALLO-B-LACTAMASE INHIBITORS MEIJI SEIKA KAISHA (JP) 2016-06-02 US disclosed
EP-1941873-A1 METALLO-BETA-LACTAMASE INHIBITOR MEIJI SEIKA KAISHA LTD. (JP) 2008-07-09 EP disclosed
EP-1941873-A1 METALLO-BETA-LACTAMASE INHIBITOR MEIJI SEIKA KAISHA LTD. (JP) 2008-07-09 EP disclosed
US-20080090825-A1 Metallo-beta-lactamase inhibitors MEIJI SEIKA KAISHA, LTD. (JP) 2008-04-17 US disclosed
US-20080090825-A1 Metallo-beta-lactamase inhibitors MEIJI SEIKA KAISHA, LTD. (JP) 2008-04-17 US disclosed
US-20080090825-A1 Metallo-beta-lactamase inhibitors MEIJI SEIKA KAISHA, LTD. (JP) 2008-04-17 US disclosed
EP-0061079-B1 POLYMER STABILIZERS GAF CORPORATION (US) 1985-07-31 EP disclosed
US-4396734-A VINYL POLYMER THICKENER, REDOX INDICATOR, MUCILAGE GAF CORPORATION (US) 1983-08-02 US disclosed
EP-0061079-A1 Polymer stabilizers GAF CORPORATION (US) 1982-09-29 EP disclosed
US-4200720-A HYDROXIDE OR NUCLEOPHILIC SALT OF A MONOVALENT CATION THE DOW CHEMICAL COMPANY (US) 1980-04-29 US disclosed
US-4180637-A Process for the preparation of low molecular weight anhydride interpolymers THE DOW CHEMICAL COMPANY (US) 1979-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090825-A1 Metallo-beta-lactamase inhibitors ME1, MGAM, GAA CALM1 2425/4885CTRC 1167/4885CYP1A2 749/4885
US-20160151322-A1 METALLO-B-LACTAMASE INHIBITORS ME1, MGAM, MANBA CALM1 2865/4885CTRC 1118/4885CYP1A2 715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.